Dr. Agarwal's Health Care · NSE: AGARWALEYE · BSE: 544350
Q2 FY26 results · Jul–Sep 2025
Dr. Agarwal's Health Care reported revenue from operations of ₹498.69 crore and net profit of ₹36.49 crore for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 498.69 | — | — | 487.42 | +2.3% |
| Other income | 7.93 | — | — | 13.39 | −40.8% |
| Total income | 506.62 | — | — | 500.81 | +1.2% |
| Profit before tax | 53.66 | — | — | 53.60 | +0.1% |
| Net profit for the period | 36.49 | — | — | 38.06 | −4.1% |
| Attributable to shareholders of the company | 29.69 | — | — | 30.05 | −1.2% |
| EPS, basic (₹) | 0.94 | — | — | 0.95 | −1.1% |
| Net margin (%) | 7.3 | — | 7.8 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 308.98 | — | — | 301.72 | +2.4% |
| Other income | 6.81 | — | — | 13.03 | −47.7% |
| Total income | 315.79 | — | — | 314.75 | +0.3% |
| Profit before tax | 9.56 | — | — | 15.59 | −38.7% |
| Net profit for the period | 4.68 | — | — | 10.11 | −53.7% |
| EPS, basic (₹) | 0.15 | — | — | 0.32 | −53.1% |
| Net margin (%) | 1.5 | — | 3.4 |
Consolidated
- Filed with BSE
- 30 Oct 2025, 21:26 IST
- Board meeting
- 30 Oct 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 Oct 2025, 21:26 IST
- Board meeting
- 30 Oct 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE